{"entity":{"id":"nct05086614","kind":"trial","name":"Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer","aka":[],"tldr":"A phase 3 trial in colorectal cancer, run by Fudan University, now recruiting.","summary":"Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer is a phase 3, randomised interventional study registered as NCT05086614 by Fudan University, with a registry enrolment figure of 2500 participants, started 2021-04-01 and due to reach its primary completion in 2027-03-31. Interventions recorded: Thymosin Alpha1. Conditions listed: Stage II Colorectal Cancer; Stage III Colorectal Cancer. Primary outcome: 3-year disease-free survival rate. Colorectal eligibility wording from the registry: \"* Colorectal cancer receiving radical resection\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05086614","url":"https://clinicaltrials.gov/study/NCT05086614"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05086614","phase":"3","setting":"The Efficacy and Safety of Thymosin-alpha 1 Used for Adjuvant Treatment After Radical Resection of High-risk Stage II and Stage III Colorectal Cancer","sponsor":"Fudan University","participation":[{"nct":"NCT05086614","source":"https://clinicaltrials.gov/study/NCT05086614","fetchedAt":"2026-10-07T16:53:34.066Z","studySha256":"816bcfc3d78dd00cd68960717aa62a34c8ba002ea1caeab5308d2f01a3448c63","overallStatus":"RECRUITING","lastUpdatePosted":"2021-10-21","leadSponsor":"Fudan University","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":2500,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2021-04-01","startedType":"actual","enrolled":2500,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05086614/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}